Former OpenAI Science Chief Launches Warp Sciences With 215 Million Dollars to Automate Drug Chemistry
Warp Sciences emerged from stealth on Thursday with 215 million dollars in funding and a plan to rebuild, in the United States, a piece of the drug discovery business that largely moved overseas: making and testing compounds. The round, led by Lightspeed, values the startup at 865 million dollars including the new money, according to the company's announcement.